Armonk, NY and Chicago, USA - August 06, 2015 - IBM (NYSE: IBM) today announced that Watson will gain the ability to "see" by bringing together Watson's advanced image analytics and cognitive capabilities with data and images obtained from Merge Healthcare Incorporated's (NASDAQ: MRGE) medical imaging management platform. IBM plans to acquire Merge, a leading provider of medical image handling and processing, interoperability and clinical systems designed to advance healthcare quality and efficiency, in an effort to unlock the value of medical images to help physicians make better patient care decisions. Merge's technology platforms are used at more than 7,500 U.S. healthcare sites, as well as most of the world's leading clinical research institutes and pharmaceutical firms to manage a growing body of medical images. The vision is that these organizations could use the Watson Health Cloud to surface new insights from a consolidated, patient-centric view of current and historical images, electronic health records, data from wearable devices and other related medical data, in a HIPAA-enabled environment.
|
Watson to Gain Ability to “See” with Planned $1 Billion Acquisition of Merge Healthcare.
Photo courtesy of IBM |
|
Armonk, NY and Chicago, USA - August 06, 2015
• Deal Brings Watson Technology Together with Leader in Medical Images
IBM (NYSE: IBM) today announced that Watson will gain the ability to “see” by bringing together Watson’s advanced image analytics and cognitive capabilities with data and images obtained from Merge Healthcare Incorporated’s (NASDAQ: MRGE) medical imaging management platform.
|
Watson to Gain Ability to “See” with Planned $1 Billion Acquisition of Merge Healthcare.
Photo courtesy of IBM |
|
IBM plans to acquire Merge, a leading provider of medical image handling and processing, interoperability and clinical systems designed to advance healthcare quality and efficiency, in an effort to unlock the value of medical images to help physicians make better patient care decisions.
|
Watson to Gain Ability to “See” with Planned $1 Billion Acquisition of Merge Healthcare.
Photo courtesy of IBM |
|
Merge’s technology platforms are used at more than 7,500 U.S. healthcare sites, as well as most of the world’s leading clinical research institutes and pharmaceutical firms to manage a growing body of medical images.
|
Watson to Gain Ability to “See” with Planned $1 Billion Acquisition of Merge Healthcare.
Photo courtesy of IBM |
|
The vision is that these organizations could use the Watson Health Cloud to surface new insights from a consolidated, patient-centric view of current and historical images, electronic health records, data from wearable devices and other related medical data, in a HIPAA-enabled environment.
|
An IBM Research project is teaching IBM Watson to see.
In the future, it could help clinicians spot patterns quickly and more precisely.
IBM is working to make healthcare smarter every day.
Photo courtesy of IBM |
|
Under terms of the transaction, Merge shareholders would receive $7.13 per share in cash, for a total transaction value of $1 billion.
The closing of the transaction is subject to regulatory review, Merge shareholder approval, and other customary closing conditions, and is anticipated to occur later this year.
|
Watson Health Cloud to surface new insights from a consolidated, patient-centric view of current and historical images, electronic health records, data from wearable devices and other related medical data, in a HIPAA-enabled environment.
Photo courtesy of IBM |
|
It is IBM’s third major health-related acquisition – and the largest – since launching its Watson Health unit in April, following Phytel (population health) and Explorys (cloud based healthcare intelligence).
|
Photo courtesy of IBM
|
|
“As a proven leader in delivering healthcare solutions for over 20 years, Merge is a tremendous addition to the Watson Health platform. Healthcare will be one of IBM’s biggest growth areas over the next 10 years, which is why we are making a major investment to drive industry transformation and to facilitate a higher quality of care,” said John Kelly, senior vice president, IBM Research and Solutions Portfolio.
“Watson’s powerful cognitive and analytic capabilities, coupled with those from Merge and our other major strategic acquisitions, position IBM to partner with healthcare providers, research institutions, biomedical companies, insurers and other organizations committed to changing the very nature of health and healthcare in the 21stcentury. Giving Watson ‘eyes’ on medical images unlocks entirely new possibilities for the industry.”
|
Photo courtesy of IBM
|
|
Teaching Watson to “See” Medical Images
The planned acquisition bolsters IBM’s strategy to add rich image analytics with deep learning to the Watson Health platform – in effect, advancing Watson beyond natural language and giving it the ability to “see.”
|
Photo courtesy of IBM |
|
Medical images are by far the largest and fastest-growing data source in the healthcare industry and perhaps the world – IBM researchers estimate that they account for at least 90% of all medical data today – but they also present challenges that need to be addressed:
• The volume of medical images can be overwhelming to even the most sophisticated specialists – radiologists in some hospital emergency rooms are presented with as many as 100,000 images a day (IBM Research estimate).
• Tools to help clinicians extract insights from medical images remain very limited, requiring most analysis to be done manually.
• At a time when the most powerful insights come at the intersection of diverse data sets (medical records, lab tests, genomics, etc.), medical images remain largely disconnected from mainstream health information.
|
Photo courtesy of IBM |
|
IBM plans to leverage the Watson Health Cloud to analyze and cross-reference medical images against a deep trove of lab results, electronic health records, genomic tests, clinical studies and other health-related data sources, already representing 315 billion data points and 90 million unique records.
|
Photo courtesy of IBM |
|
Merge’s clients could compare new medical images with a patient’s image history as well as populations of similar patients to detect changes and anomalies.
Insights generated by Watson could then help healthcare providers in fields including radiology, cardiology, orthopedics and ophthalmology to pursue more personalized approaches to diagnosis, treatment and monitoring of patients.
|
Photo courtesy of IBM |
|
Cutting-edge image analytics projects underway in IBM Research’s global labs suggest additional areas where progress can be made.
They include teaching Watson to filter clinical and diagnostic imaging information to help clinicians identify anomalies and form recommendations, which could help reduce physician viewing loads and increase physician effectiveness.
|
Photo courtesy of IBM |
|
“As Watson evolves, we are tackling more complex and meaningful problems by constantly evaluating bigger and more challenging data sets,” Kelly said.
“Medical images are some of the most complicated data sets imaginable, and there is perhaps no more important area in which researchers can apply machine learning and cognitive computing. That’s the real promise of cognitive computing and its artificial intelligence components – helping to make us healthier and to improve the quality of our lives.”
|
Photo courtesy of IBM |
|
Watson Health and Merge Capabilities Will Benefit Researchers, Clinicians and Individuals
IBM’s Watson Health unit plans to bring together Merge’s product and solution offerings with existing expertise in cognitive computing, population health, and cloud-based healthcare intelligence offerings to:
• Offer researchers insights to aid clinical trial design, monitoring and evaluation;
• Help clinicians to efficiently identify options for the diagnosis, treatment and monitoring a broad array of health conditions such as cancer, stroke and heart disease;
• Enable providers and payers to integrate and optimize patient engagement in alignment with meaningful use and value-based care guidelines; and
• Support researchers and healthcare professionals as they advance the emerging discipline of population health, which aims to optimize an individual’s care by identifying trends in large numbers of people with similar health status.
|
Photo courtesy of IBM |
|
“Merge is widely recognized for delivering market leading imaging workflow and electronic data capture solutions,” said Justin Dearborn, chief executive officer, Merge.
“Today’s announcement is an exciting step forward for our employees and clients. Becoming a part of IBM will allow us to expand our global scale and deliver added value and insight to our clients through Watson’s advanced analytic and cognitive computing capabilities.”
|
Photo courtesy of IBM |
|
“Combining Merge’s leading medical imaging solutions with the world-class machine learning and analytics capabilities of IBM’s Watson Health is the future of healthcare technology,” said Michael W. Ferro, Jr., Merge’s chairman.
“Merge’s leading technology and proven expertise represent a unique combination of assets that will deliver unparalleled value to Watson Health clients. Together, we will unlock unprecedented new opportunities to improve patient diagnostics and deliver enhanced care.”
|
Photo courtesy of IBM |
|
About Merge
Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare.
Merge’s enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time.
|
Photo courtesy of IBM |
|
Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions.
With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs, improve efficiencies and enhance the quality of healthcare worldwide.
|
Photo courtesy of IBM |
|
For more information, visit merge.com and follow us @MergeHealthcare.
IBM Watson: Pioneering a New Era of Computing
Watson is the first commercially available cognitive computing capability representing a new era in computing.
The system, delivered through the cloud, analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers.
Watson continuously learns, gaining in value and knowledge over time, from previous interactions.
|
Photo courtesy of IBM |
|
In January 2014, IBM launched the IBM Watson unit, a business dedicated to developing and commercializing cloud-delivered cognitive computing technologies.
The move signified a strategic shift by IBM to deliver a new class of software, services and apps that improves by learning, and discovers insights from massive amounts of Big Data.
As part of the unit, the company has increased the number and diversity of cognitive computing services delivered to its partners, adding new beta Watson services in February 2015, and scalable deep learning APIs with the acquisition of AlchemyAPI in March 2015.
|
Photo courtesy of IBM |
|
In April 2015, the company continued to build on its strengths in cognitive computing, analytics, security and cloud with the launch of IBM Watson Health and the Watson Health Cloud platform.
The new unit will help improve the ability of doctors, researchers and insurers to innovate by surfacing new insights from the massive amount of personal health data being created daily.
|
Photo courtesy of IBM |
|
The Watson Health Cloud allows this information to be anonymized, shared and combined with a dynamic and constantly growing aggregated view of clinical, research and social health data.
About IBM
For more information on IBM Watson, visit: ibm.com/watson.
For more information on IBM Watson Health, visit: ibm.com/watsonhealth
Check out the IBM Watson press kit at:
http://www-03.ibm.com/press/us/en/presskit/27297.wss
Join the conversation at #ibmwatson and #watsonhealth.
Follow Watson on Facebook and see Watson on YouTube and Flickr.
Learn more about this story at:
http://asmarterplanet.com/blog/2015/08/seeing-believing-bringing-cognitive-image-analytics-healthcare.html
Contacts information
Christine Douglass
IBM Media Relations
M: 415-535-4479
cgdouglass@us.ibm.com
Michael R. Klozotsky
Vice President, Corporate Marketing Merge Healthcare Media Relations
312.946.2535
312.895.4700
michael.klozotsky@merge.com
Source: IBM
http://www-03.ibm.com/press/us/en/index.wss
ASTROMAN Magazine - 2015.07.11
IBM Research Alliance Produces Industry's First 7nm Node Test Chips
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1936
ASTROMAN Magazine - 2015.06.27
IBM Research: Internet of Things Turning New York's Lake George into "World's Smartest Lake”
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1932
ASTROMAN Magazine - 2015.05.31
Doctor Evidence Brings Valuable Health Data to IBM Watson Ecosystem
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1923
ASTROMAN Magazine - 2015.05.02
Japan Post Group, IBM and Apple Deliver iPads and Custom Apps to Connect Elderly in Japan to Services, Family and Community
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1913
ASTROMAN Magazine - 2015.03.22
IBM Invests in Modernizing Medicine to Accelerate Adoption of Watson Technologies in Healthcare
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1893
ASTROMAN Magazine - 2015.02.22
IBM Studio Opens in London to Transform the Client Experience
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1876
ASTROMAN Magazine - 2015.01.19
IBM Launches z13 Mainframe - Most Powerful and Secure System Ever Built
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1863
ASTROMAN Magazine - 2014.12.24
IBM Named a Worldwide Leader in IDC MarketScape for Mobile Application Development and Testing Consulting Services
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1852
ASTROMAN Magazine - 2014.10.26
IBM and Microsoft to Offer Greater Choice in the Hybrid Cloud
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1818
ASTROMAN Magazine - 2014.10.21
GLOBALFOUNDRIES to Acquire IBM's Microelectronics Business
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1813
ASTROMAN Magazine - 2014.10.16
The Internet of Things World Forum Unites Industry Leaders in Chicago to Accelerate the Adoption of IoT Business Models
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1810
ASTROMAN Magazine - 2014.08.30
IBM Watson Ushers in a New Era of Data-Driven Discoveries
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1783
ASTROMAN Magazine - 2014.08.10
Wroclaw University of Technology Delivers Personalized Classrooms on IBM Cloud Infrastructure
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1772
ASTROMAN Magazine - 2014.08.02
IBM acquires CrossIdeas to Expand Security Offerings with Identity Intelligence
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1767
ASTROMAN Magazine - 2014.07.16
Apple and IBM Forge Global Partnership to Transform Enterprise Mobility
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1757
ASTROMAN Magazine - 2014.07.12
IBM Announces $3 Billion Research Initiative to Tackle Chip Grand Challenges for Cloud and Big Data Systems
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1755
ASTROMAN Magazine - 2014.07.08
City of Madrid Implements IBM's Large Smarter Cities Environmental Analytics Project
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1751
ASTROMAN Magazine - 2014.06.27
Qatar Public Works Authority 'Ashghal' Selects IBM for Smarter Infrastructure
https://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1741
ASTROMAN Magazine - 2014.05.11
Report: IBM Named #1 Preferred Provider of IaaS Cloud by Enterprises
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1710
ASTROMAN Magazine – 2014.02.01
IBM and Twitter Announce Patent and Cross-License Agreement. Twitter purchases 900 patents from IBM
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1648
ASTROMAN Magazine - 2013.12.22
IBM to Acquire Aspera to Help Companies Speed Global Movement of Big Data
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1610
Editor-in-Chief of ASTROMAN magazine: Roman Wojtala, PhD.
|